Almirall
Every public sector contract Almirall has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Almirall for you, and alerts you the moment a renewal goes live.
Where they win
The sectors, tender types and buyers where Almirall wins most often.
See every live NHS tenders and find your next contract before they do.
Similar suppliers
See all NHS buyers and UK contract awards.
Sectors
Top Buyers
Awards(20)
Spain – Various medicinal products – suministro de los principios activos denominados "DRONABINOL + CANNABIDIOL y "LEBRIKIZUMAB250 MG" para el Hospital Universitario de Gran Canaria Dr. Negrín.
Spain – Various medicinal products – Suministro del principio activo denominado "TILDRAKIZUMAB 100 MG JERINGA SC" para el Hospital Universitario de Gran Canaria Dr.Negrín.
Spain – Pharmaceutical products – Suministro de Combinación de Delta9Tetrahidrocannabinol y Cannabidiol (DOE)
Spain – Pharmaceutical products – CBAM 578/2025 ALMIRALL
Spain – Various medicinal products – Suministro del producto farmacéutico Lebrikizumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.
Spain – Pharmaceutical products – EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208790, CON LA EMPRESA ALMIRALL, S.A
Spain – Pharmaceutical products – CONTR 2026 200966 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS
NP90726l Tildrakizumab (Ilumetri®)
Spain – Pharmaceutical products – SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: LEBRIKIZUMAB (EBGLYSS)
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
NHS South of England Branded Medicines - Tranche A - September 2023
NHS London Branded Medicines - Tranche B - September 2023
NHS National Generic Pharmaceuticals Wave 14b
NP93923a Dimethyl Fumarate (Skilarence®)
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche
Suministro de medicamentos exclusivos: Tildrakizumab (ILUMETRI) y Dronabinol/Cannabidiol (SATIVEX).Prórroga 2ª P.N.S.P. 30/2020.
Tildrakizumab (Ilumetri®)
NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual
Suministro de Medicamentos Exclusivos: Medicamentos: tetrahidrocannabinol / cannabidiol, tildrakizumab para el Hospital General Universitario Gregorio Marañón
Why track Almirall?
Almirall is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.
How renewal tracking works
We aggregate Almirall's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.
What you can do here
- Review the full history. Every contract Almirall has won, with the buyer, value and dates for each.
- Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
- Track and get alerted. Follow Almirall and be notified when their contracts come up again (Business).
- Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.
Frequently asked questions
Where does this data come from?
Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.
Is the contract history free?
Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.
How do you predict renewals?
From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.